Arachidonic acid metabolism, pain and hyperalgesia: the mode of action of non-steroid mild analgesics.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 1430162)

Published in Br J Clin Pharmacol on October 01, 1980

Authors

G A Higgs

Articles citing this

The mechanisms of action of NSAIDs in analgesia. Drugs (1996) 1.14

Articles cited by this

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol (1971) 37.53

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (1976) 13.19

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A (1975) 10.82

Prostaglandins: their disappearance from and release into the circulation. Nature (1967) 8.66

Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci U S A (1974) 8.30

Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol (1971) 7.75

Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci U S A (1974) 7.00

Indomethacin and aspirin abolish prostaglandin release from the spleen. Nat New Biol (1971) 5.62

Prostaglandins, aspirin-like drugs and analgesia. Nat New Biol (1972) 4.91

Arachidonate lipoxygenase in blood platelets. Biochim Biophys Acta (1975) 2.84

ACTION OF PROSTAGLANDIN E1 ON TISSUES WHICH RESPOND TO BRADYKININ. Nature (1963) 2.48

Cutaneous reactions to intradermal prostaglandins. Br J Pharmacol (1971) 2.27

An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance. Prostaglandins (1974) 2.02

SITE OF ACTION OF NARCOTIC AND NON-NARCOTIC ANALGESICS DETERMINED BY BLOCKING BRADYKININ-EVOKED VISCERAL PAIN. Arch Int Pharmacodyn Ther (1964) 1.91

Role of prostaglandin endoperoxide PGG2 in inflammatory processes. Nature (1977) 1.89

Cutaneous vascular reactions to prostaglandins in healthy subjects and in patients with urticaria and atopic dermatitis. Acta Derm Venereol (1969) 1.51

Prostaglandins as mediators of inflammation. Adv Prostaglandin Thromboxane Res (1976) 1.48

Prostaglandin on cutaneous vasculature. J Invest Dermatol (1968) 1.45

Action of prostaglandin in the pregnant woman. Ann N Y Acad Sci (1971) 1.42

Aspirin and algesimetry. Nature (1959) 1.37

Effect of prostaglandin E1 on forearm blood flow. Scand J Clin Lab Invest (1969) 1.06

Prostaglandin-oxytocin enhancement and potentiation and their clinical applications. Br Med J (1972) 1.00

Actions and interactions of prostaglandins administered intradermally in rat and in man. Br J Pharmacol (1969) 1.00

A pharmacological analysis of aspirin. Adv Pharmacol Chemother (1969) 0.99

Inflammatory effects of prostacyclin (PGI2) and 6-oxo-PGF1alpha in the rat paw. Prostaglandins (1978) 0.95

Microcirculatory effects of prostacyclin (PGI2) in the hamster cheek pouch. Microvasc Res (1979) 0.79

Articles by these authors

Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci U S A (1986) 3.78

A new approach to anti-inflammatory drugs. Biochem Pharmacol (1979) 2.95

A chemotactic role for prostaglandins released from polymorphonuclear leucocytes during phagocytosis. Br J Pharmacol (1975) 2.79

Chemokinetic activity of arachidonic and lipoxygenase products on leuocyctes of different species. Prostaglandins (1980) 2.59

Proceedings: Prostaglandin production by rabbit peritoneal polymorphonuclear leukocytes in vitro. Br J Pharmacol (1972) 2.53

Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature (1980) 2.24

Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity. Proc Natl Acad Sci U S A (1987) 1.80

Eicosanoids in inflammation. Ann Clin Res (1984) 1.50

The effects of non-steroid anti-inflammatory drugs on leukocyte migration in carrageenin-induced inflammation. Eur J Pharmacol (1980) 1.48

Polymorphonuclear leukocytes produce thromboxane A2-like activity during phagocytosis. Prostaglandins (1976) 1.40

The effects of antiinflammatory drugs on the production of prostaglandins in vivo. Adv Prostaglandin Thromboxane Res (1976) 1.36

The inflammatory effects of hydroperoxy and hydroxy acid products of arachidonate lipoxygenase in rabbit skin. Br J Pharmacol (1981) 1.25

Mediators of rheumatoid arthritis. Br Med Bull (1987) 1.23

Inhibition of arachidonic acid cyclo-oxygenase and lipoxygenase activities of leukocytes by indomethacin and compound BW755C. Agents Actions (1980) 1.21

The source of thromboxane and prostaglandins in experimental inflammation. Br J Pharmacol (1983) 1.17

Prostaglandins and leukotrienes as inflammatory mediators. Br Med Bull (1987) 1.11

Inhibition of cyclo-oxygenase and lipoxygenase. Br Med Bull (1983) 1.09

Leucocyte infiltration and cartilage proteoglycan loss in immune arthritis in the rabbit. Br J Pharmacol (1988) 1.08

Synthesis of arachidonate oxidation products by synovial joint tissues during the development of chronic erosive arthritis. Arthritis Rheum (1987) 1.08

Eicosapentaenoic acid as a modulator of inflammation. Effect on prostaglandin and leukotriene synthesis. Biochem Pharmacol (1986) 1.02

Prostacyclin (PGI2) inhibits the formation of platelet thrombi induced by adenosine diphosphate (ADP) in vivo [proceedings]. Br J Pharmacol (1977) 0.97

PAF-acether in chronic arthritis. Agents Actions (1987) 0.97

Synthesis of arachidonate cyclo-oxygenase products by rheumatoid and nonrheumatoid synovial lining in nonproliferative organ culture. Ann Rheum Dis (1983) 0.96

Inhibition by neuropeptides of interleukin-1 beta-induced, prostaglandin-independent hyperalgesia. Br J Pharmacol (1989) 0.93

Eicosanoids and inflammation. J Pathol (1988) 0.90

Effect of the glucocorticosteroid budesonide and a novel phosphodiesterase type 4 inhibitor CDP840 on antigen-induced airway responses in neonatally immunised rabbits. Br J Pharmacol (1996) 0.88

Effect of indomethacin on swelling, lymphocyte influx, and cartilage proteoglycan depletion in experimental arthritis. Ann Rheum Dis (1989) 0.87

A photometric device for measuring blood vessel diameter in the microcirculation. J Pharmacol Methods (1980) 0.86

Leukotrienes in disease. Implications for drug development. Drugs (1985) 0.84

Inflammatory properties of lipoxygenase products and the effects of indomethacin and BW755C on prostaglandin production, leukocyte migration, and plasma exudation in rabbit skin. Adv Prostaglandin Thromboxane Leukot Res (1982) 0.84

Prostacyclin as a potent dilator of arterioles in the hamster cheek pouch [proceedings]. J Physiol (1978) 0.84

The effects of a novel series of selective inhibitors of arachidonate 5-lipoxygenase on anaphylactic and inflammatory responses. Ann N Y Acad Sci (1988) 0.83

Chemotherapeutic potential of phosphodiesterase inhibitors. Curr Opin Chem Biol (1998) 0.83

Synthesis of eicosanoids by tissues of the synovial joint during the development of chronic erosive synovitis. Agents Actions (1986) 0.81

Effects of theophylline and rolipram on antigen-induced airway responses in neonatally immunized rabbits. Br J Pharmacol (1996) 0.81

Generation of thromboxane A2-like activity from prostaglandin endoperoxides by polymorphonuclear leukocyte homogenates [proceedings]. Br J Pharmacol (1976) 0.81

Effects of antiinflammatory agents on chronic Salmonella typhimurium infection in a mouse model. Infect Immun (1983) 0.79

Mode of action of benoxaprofen. Lancet (1984) 0.79

Microcirculatory effects of prostacyclin (PGI2) in the hamster cheek pouch. Microvasc Res (1979) 0.79

CDP840: a novel inhibitor of PDE-4. Cell Biochem Biophys (1998) 0.79

Arthritogenic activity of interleukin 1. Agents Actions (1986) 0.79

Inhibition of tissue damage by the arachidonate lipoxygenase inhibitor BW755C. Proc Natl Acad Sci U S A (1984) 0.79

Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch. Br J Pharmacol (1978) 0.79

A photometric device for measuring blood vessel diameter in the microcirculation [proceedings]. J Physiol (1978) 0.79

The effects of dietary intake of essential fatty acids on prostaglandin and leukotriene synthesis. Proc Nutr Soc (1985) 0.78

Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch. 1977. Br J Pharmacol (1997) 0.78

Recombinant tissue inhibitor of metalloproteinases type 1 suppresses alkali-burn-induced corneal ulceration in rabbits. Invest Ophthalmol Vis Sci (1994) 0.78

Inhibition of arachidonic acid cyclo-oxygenase and lipoxygenase activities of leukocytes by indomethacin and compound BW755C. 1980. Agents Actions (1994) 0.77

Prostacyclin modulates the responses to leukotrienes C4 and D4 of guinea-pig airway smooth muscle. Eur J Pharmacol (1984) 0.77

Prostacyclin reduces the number of 'slow moving' leucocytes in hamster cheek pouch venules [proceedings]. J Physiol (1978) 0.76

Topical indomethacin and psoriasis. Br J Clin Pharmacol (1988) 0.75

The effects of lipoxygenase inhibitors in anaphylactic and inflammatory responses in vivo. Prostaglandins Leukot Med (1984) 0.75

An improved method for the extraction of prostaglandins. Prostaglandins (1973) 0.75

The effect of BW 540C, a novel anti-inflammatory agent, on ultraviolet-induced physical and histological changes in guinea-pig skin. Br J Dermatol (1985) 0.75

Studies on interleukin-1-induced arthritis. Dev Biol Stand (1988) 0.75

Inhibition of mononuclear leukocyte accumulation by the arachidonic acid lipoxygenase inhibitor BW755C. Adv Prostaglandin Thromboxane Leukot Res (1983) 0.75

Arachidonic acid metabolism in inflammation and the mode of action of anti-inflammatory drugs. Agents Actions Suppl (1979) 0.75

Detection of prostaglandin-like activity in equine inflammatory exudate--a preliminary report. Equine Vet J (1984) 0.75